Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Northern Green Canada is a vertically integrated Canadian licensed producer specializing in the cultivation and processing of medical-grade cannabis. The company is distinguished by its EU-GMP (European Union Good Manufacturing Practice) certification, which allows it to export high-quality pharmaceutical cannabis products to international markets, particularly Germany and Israel. Northern Green Canada focuses on science-based cultivation techniques and rigorous quality control to provide consistent therapeutic options for patients. In April 2024, the company was acquired by Curaleaf Holdings, a move intended to strengthen Curaleaf's international supply chain and European market presence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Northern Green Sciences.